InMed Pharmaceuticals Inc.
INM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001728328
In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 4 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding InMed Pharmaceuticals Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 5 | 5 | 0 |
| Shares | 48.9K | 6.41K | −42.5K (−86.9%) |
| Value | $226.7K | $13.3K | −$213.4K (−94.1%) |
New holders (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| SBI Securities Co., Ltd. | 300 | $621 | 0.00% |
| Banque Cantonale Vaudoise | 6 | $0 | 0.00% |
Sold out (2)
Institutions that held InMed Pharmaceuticals Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| AdvisorShares Investments LLC | 38,460 | $177.3K |
| Danske Bank A/S | 1 | $5 |